StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen interest and other income, net ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, Q2 2026
125
Period ended Jun 30, 2026
Change on a year earlier
+45.3%
86 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
6
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInterest and other income, net ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026125+45.3%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026101-19.8%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 202597-16.4%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 202599-21.4%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 202586-25.2%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 2025126-17.6%Form 10-Q (filed 2025-05-02) ↗
Q4 2024Dec 31, 2024116–Form 10-Q (filed 2025-11-05) ↗
Q3 2024Sep 30, 2024126–Form 10-Q (filed 2025-11-05) ↗
Q2 2024Jun 30, 2024115–Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 2024153–Form 10-Q (filed 2025-05-02) ↗

Cite this data

StockData. (2026). Amgen Interest and other income, net ($M) ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_int_inc

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.